BioSpace News Archive

Pharm Country

Global Healthy Living Foundation to Present at the VA Medical Device Registry Summit

Patient Representative for the ArthritisPower™ Research Registry to Offer Remarks

June 4, 2018
·
4 min read
Policy

Thermi Announces Settlement of Patent Infringement Litigation with Viveve

ThermiGen, LLC announced that it has reached a settlement with Viveve Medical, Inc. to resolve the patent litigation that was filed in 2016 .

June 4, 2018
·
2 min read
BioMidwest

DNV GL Healthcare Accredits First Provider For Palliative Care

DNV GL Healthcare has certified Hillcrest Medical Center in Tulsa, Oklahoma for palliative care services.

June 4, 2018
·
3 min read
Genetown

AMAG PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FILING FOR BREMELANOTIDE

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for bremelanotide.

June 4, 2018
·
7 min read
Business

NYU Langone Opens State-of-the-Art Hospital Pavilion, with City’s Newest Pediatric Hospital Facility in 15 Years

On June 24, NYU Langone Health will open the doors to a new inpatient facility, the Helen L. and Martin S. Kimmel Pavilion, adding significantly to the healthcare space in New York City and offering private rooms for all patients.

June 4, 2018
·
9 min read
Business

Kilroy Realty Acquires Key Life Science Development Site in South San Francisco

Fully Entitled for 2.5 Million Square Feet of Lab and Office Space

June 4, 2018
·
7 min read
Drug Development

Merck Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018

M7824 is an investigational immunotherapy that is designed to bring together both anti-transforming growth factor-β and anti-PD-L1 mechanisms

June 4, 2018
·
5 min read
Business

New Leaf Ventures Names Martin Mackay, Ph.D., as Senior Advisor

Seasoned Biopharma R&D Executive Brings More Than 30 Years of Expertise to New Leaf and Its Portfolio of Healthcare and Technology Companies

June 4, 2018
·
2 min read
Drug Development

Synlogic Presents New Preclinical Data from Synthetic BioticTM Medicine, SYNB1020, Highlighting Beneficial Activity in Animal Model of Liver Disease at Digestive Disease Week®

SYNB1020 currently being evaluated in a Phase 1b/2a clinical trial in patients with elevated ammonia due to cirrhosis; topline data expected by YE2018.

June 4, 2018
·
6 min read
Pharm Country

22nd Century to Present to Institutional Investors at the Citi 2018 Small & Mid Cap Conference

22nd Century Group, Inc. announced that the Company will present at the Citi 2018 Small & Mid Cap Conference.

June 4, 2018
·
3 min read